Posted on Leave a comment

USDA Reports on Highly Pathogenic Avian Influenza in the US – The National Law Review

On May 27, 2022, the U.S. Department of Agriculture (USDA) reported that Agriculture Secretary Tom Vilsack had approved funds to support USDA’s Animal and Plant Health Inspection Service (APHIS) in its response efforts to the outbreak of highly pathogenic avian influenza (HPAI) in the United States.
HPAI requires a rapid response because it is highly contagious and often fatal to poultry. The virus has been confirmed in 35 states, affecting more than 37.9 million domestic birds.  To help ensure that APHIS can continue to perform its response activities, Secretary Vilsack has approved the transfer of $400 million from the Commodity Credit Corporation to APHIS.  Secretary Vilsack had previously approved about $130 million in emergency funding in March, along with an additional $263 million in April.
USDA encourages bird owners to ensure domestic birds do not come into contact with wild birds and to keep poultry confined inside during this high-risk period of migratory bird activity.  Resources for bird owners and more information about the HPAI response may be found here.
About this Author
Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition…
As a woman owned company, The National Law Review is a certified member of the Women's Business Enterprise National Council
You are responsible for reading, understanding and agreeing to the National Law Review’s (NLR’s) and the National Law Forum LLC’s  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  
Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is  intended to be  a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 
Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.
The National Law Review – National Law Forum LLC 3 Grant Square #141 Hinsdale, IL 60521  Telephone  (708) 357-3317 or toll free (877) 357-3317.  If you would ike to contact us via email please click here.


Leave a Reply